- These firms will carry out independent analyses, projections and recommendations on the Company, based on its financial and operational performance.
- JB Capital initiated coverage on December 12th, with a Buy recommendation and a target price of €2.0 (a potential increase of 24.2%12)
- Marex initiated coverage on October 31st, with a Buy recommendation and a target price of €2.1 (representing a potential upside of 30.4%)
JB Capital and Marex, prestigious independent financial services firms, have initiated sponsored coverage of its stock with a buy recommendation. Both firms will conduct independent analyses, projections, and recommendations on the company, based on its financial and operational performance.
Marex initiated coverage on October 31st, including in its report a buy recommendation and a target price of €2.1 per share. Meanwhile, JB Capital initiated coverage on December 12th highlighting a buy recommendation and assigning a target price of €2.0 for Facephi’s stock.
Javier Mira, CEO of Facephi, comments: “In line with our commitment to communication and transparency, we are pleased to have two internationally renowned independent firms evaluating Facephi’s financial and operational performance. These new coverage initiations, along with the appointment of Evercom as our financial communications agency and the addition of Antonio Jorge as Head of Investor Relations, reflect our determination to strengthen our relationship with the market by providing detailed, reliable, and timely information from both internal and external sources.”
